Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges and opportunities in biotechnology.

L R Overby

    Progress in Clinical and Biological Research
    |January 1, 1985
    PubMed
    Summary

    Biotechnology advances like gene cloning are routine, yielding initial products. Future innovations in recombinant DNA technology promise significant impacts on healthcare and pharmaceuticals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hepatitis C: looking at a virus that hasn't been seen.

    Gut·1993
    Same author

    Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

    British medical bulletin·1990
    Same author

    Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

    Science (New York, N.Y.)·1989
    Same author

    Science and technology in mitigating AIDS.

    Transfusion medicine reviews·1988
    Same author

    A specific immune response to purified HA antigen (HAAg) demonstrated by leukocyte migration inhibition in patients recovering from viral hepatitis A.

    Journal of hepatology·1986
    Same author

    Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B.

    Journal of medical virology·1984

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Genetics

    Background:

    • The biotechnology industry has seen significant advancements in the last decade.
    • Gene cloning and expression are now routine procedures.
    • Early commercial products have emerged, but clinical significance requires further evaluation.

    Purpose of the Study:

    • To outline the expected impact of biotechnology on healthcare and the pharmaceutical industry over the next decade.
    • To highlight the potential of first- and second-generation recombinant DNA products.
    • To identify future opportunities in drug discovery and development.

    Main Methods:

    • Review of current biotechnology achievements and predicted advancements.
    • Analysis of the role of recombinant DNA (rDNA) technologies in product development.
    • Exploration of potential new delivery systems and gene reconstruction.

    Main Results:

    • Recombinant vaccines, blood coagulation factors, and biological modulators are expected to see widespread use.
    • New bioactive molecules and infectious agents (e.g., NANB hepatitis, AIDS) present further opportunities.
    • Exploitation of healthcare products hinges on novel delivery systems and gene reconstruction.

    Conclusions:

    • Biotechnology is poised to substantially influence human healthcare and pharmaceuticals.
    • Continued discovery and technological innovation are key to realizing full potential.
    • Advanced delivery systems and gene engineering are crucial for in-situ product application.

    Related Experiment Videos